Fierce Biotech (2)

With almost two more years having passed since the company successfully lobbied the FDA to expand its Nerivio neuromodulation armband indication as an acute migraine treatment from adults only to all patients aged 12 and older with episodic or chronic migraine, Theranica is once again asking the agency to expand the device’s approved usage. Its […]